In 19 women with symptoms of HMB, approximately half of whom had fibroids present in the uterus, no significant reduction was observed in the average volume of the uterus after either two or three 12-week courses of treatment with a PR modulator (UPA), irrespective of whether fibroids were present. This evidence concerns the gene PGR and leiomyoma.